Benjamin Halladay serves as Executive at Esperion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Benjamin Halladay has executed 6 insider transactions totaling $46.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 17, 2025 involved selling 7,337 shares valued at $26.9K.
Benjamin Halladay currently holds 467,525 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin Halladay has been a net seller of ESPR stock. They have purchased $0 and sold $46.7K worth of shares.
Benjamin Halladay's most recent insider trade was on Dec 17, 2025, when they sold 7,337 shares at $3.67 per share.
Get notified when new Form 4 filings are submitted
| $2.81 |
| Discretionary |
| Jul 17, 2025 | ESPR | $12 | Sale | 11 | $1.12 | Discretionary |
| Mar 14, 2024 | ESPR | $0 | Award | 170,000 | $N/A | Discretionary |
| Mar 14, 2023 | ESPR | $0 | Award | 9,200 | $N/A | Discretionary |
| Dec 9, 2022 | ESPR | $0 | Award | 44,000 | $N/A | Discretionary |